These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
171 related articles for article (PubMed ID: 6358036)
1. Membrane changes induced by exposure of Escherichia coli to human serum. Kroll HP; Bhakdi S; Taylor PW Infect Immun; 1983 Dec; 42(3):1055-66. PubMed ID: 6358036 [TBL] [Abstract][Full Text] [Related]
2. Stable insertion of C5b-9 complement complexes into the outer membrane of serum treated, susceptible Escherichia coli cells as a prerequisite for killing. Kroll HP; Voigt WH; Taylor PW Zentralbl Bakteriol Mikrobiol Hyg A; 1984 Dec; 258(2-3):316-26. PubMed ID: 6397947 [TBL] [Abstract][Full Text] [Related]
3. Multimeric C9 within C5b-9 is required for inner membrane damage to Escherichia coli J5 during complement killing. Bloch EF; Schmetz MA; Foulds J; Hammer CH; Frank MM; Joiner KA J Immunol; 1987 Feb; 138(3):842-8. PubMed ID: 3100618 [TBL] [Abstract][Full Text] [Related]
4. Studies on the mechanism of bacterial resistance to complement-mediated killing. VI. IgG increases the bactericidal efficiency of C5b-9 for E. coli 0111B4 by acting at a step before C5 cleavage. Joiner KA; Goldman RC; Hammer CH; Leive L; Frank MM J Immunol; 1983 Nov; 131(5):2570-5. PubMed ID: 6355297 [TBL] [Abstract][Full Text] [Related]
5. Interaction of human complement proteins with serum-sensitive and serum-resistant strains of Escherichia coli. Taylor PW; Kroll HP Mol Immunol; 1984 Jul; 21(7):609-20. PubMed ID: 6379418 [TBL] [Abstract][Full Text] [Related]
6. Mechanism of bacterial resistance to complement-mediated killing: inserted C5b-9 correlates with killing for Escherichia coli O111B4 varying in O-antigen capsule and O-polysaccharide coverage of lipid A core oligosaccharide. Joiner KA; Schmetz MA; Goldman RC; Leive L; Frank MM Infect Immun; 1984 Jul; 45(1):113-7. PubMed ID: 6203836 [TBL] [Abstract][Full Text] [Related]
7. The interaction of Escherichia coli with normal human serum: the kinetics of serum-mediated lipopolysaccharide release and its dissociation from bacterial killing. Tesh VL; Duncan RL; Morrison DC J Immunol; 1986 Aug; 137(4):1329-35. PubMed ID: 3525676 [TBL] [Abstract][Full Text] [Related]
8. Studies of the mechanism of bacterial resistance to complement-mediated killing. V. IgG and F(ab')2 mediate killing of E. coli 0111B4 by the alternative complement pathway without increasing C5b-9 deposition. Joiner KA; Goldman RC; Hammer CH; Leive L; Frank MM J Immunol; 1983 Nov; 131(5):2563-9. PubMed ID: 6355296 [TBL] [Abstract][Full Text] [Related]
9. Killing of an encapsulated strain of Escherichia coli by human serum. Taylor PW; Kroll HP Infect Immun; 1983 Jan; 39(1):122-31. PubMed ID: 6185430 [TBL] [Abstract][Full Text] [Related]
10. Bacterial killing by complement. C9-mediated killing in the absence of C5b-8. Dankert JR; Esser AF Biochem J; 1987 Jun; 244(2):393-9. PubMed ID: 3311029 [TBL] [Abstract][Full Text] [Related]
11. C5b-7 and C5b-8 precursors of the membrane attack complex (C5b-9) are effective killers of E. coli J5 during serum incubation. Bloch EF; Knight EM; Carmon T; McDonald-Pinkett S; Carter J; Boomer A; Ogunfusika M; Petersen M; Famakin B; Aniagolu J; Walker J; Gant R; Walters CS; Gaither TA Immunol Invest; 1997 Jun; 26(4):409-19. PubMed ID: 9246562 [TBL] [Abstract][Full Text] [Related]
12. Serum-resistant strains of Borrelia burgdorferi evade complement-mediated killing by expressing a CD59-like complement inhibitory molecule. Pausa M; Pellis V; Cinco M; Giulianini PG; Presani G; Perticarari S; Murgia R; Tedesco F J Immunol; 2003 Mar; 170(6):3214-22. PubMed ID: 12626580 [TBL] [Abstract][Full Text] [Related]
13. Complement-mediated killing of the Lyme disease spirochete Borrelia burgdorferi. Role of antibody in formation of an effective membrane attack complex. Kochi SK; Johnson RC; Dalmasso AP J Immunol; 1991 Jun; 146(11):3964-70. PubMed ID: 2033266 [TBL] [Abstract][Full Text] [Related]
14. Multimeric C9 within C5b-9 deposits in unique locations in the cell wall of Salmonella typhimurium. Joiner KA; Tartanian AB; Hammer CH; Schweinle JE J Immunol; 1989 Jun; 142(12):4450-7. PubMed ID: 2656866 [TBL] [Abstract][Full Text] [Related]
15. Does complement kill E. coli by producing transmural pores? Born J; Bhakdi S Immunology; 1986 Sep; 59(1):139-45. PubMed ID: 3530981 [TBL] [Abstract][Full Text] [Related]
16. Transfer of preformed terminal C5b-9 complement complexes into the outer membrane of viable gram-negative bacteria: effect on viability and integrity. Tomlinson S; Taylor PW; Luzio JP Biochemistry; 1990 Feb; 29(7):1852-60. PubMed ID: 2184889 [TBL] [Abstract][Full Text] [Related]
18. Studies on serum resistance in Escherichia coli. Kubens BS; Opferkuch W Zentralbl Bakteriol Mikrobiol Hyg A; 1988 Nov; 270(1-2):52-65. PubMed ID: 3146846 [TBL] [Abstract][Full Text] [Related]
19. The deposition of C5b-9 complexes and its precursors on E. coli J5 during complement activation enhances uptake and toxicities of gentamicin. Bloch EF; Morrison K; McDonald-Pinkett S; Baskin S; Campbell S; Peters S; Dillahunt S; Evans D; Lucas S; Macatangay A; Kanaan Y Immunol Invest; 2008; 37(3):245-61. PubMed ID: 18389443 [TBL] [Abstract][Full Text] [Related]
20. Isolation and properties of complement-resistant strains of Escherichia coli K-12. Akiyama Y; Inoue K Infect Immun; 1977 Nov; 18(2):446-53. PubMed ID: 336545 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]